Aardvark Therapeutics, Inc. AARD
0.92 USD -0.08 (-7.74%)
Regular-session close
0.93 +0.01 +0.80%
After hours · Nov 20, 4:00 PM ET
0.90 Day range 1.06
0.91 52-week range 15.82
- YTD
- -92.97%
- 1 year
- -90.22%
5D -0.4874 (-34.57%)
- Market cap
- 20.20M
- EPS (ttm)
- -3.33
- YTD return
- -92.97%
- 1-year return
- -90.22%
- Volume
- 241.08K
- Avg volume
- 642.48K
- Open
- 1.00
- Previous close
- 1.00
- Day's range
- 0.90 – 1.06
- 52-week range
- 0.91 – 15.82
Fundamental scorecard
4 of 25 checks passed on AARD’s reported financials
4of 25 checks passed
- Value 0 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
AARD Revenue — quarterly 0
AARD Net income — quarterly -19.19M
AARD EPS — quarterly -0.88
News
Aardvark Therapeutics Q3 EPS $(0.88) Misses $(0.77) Estimate
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Pre-Market Session HC Wainwright & Co. Maintains Neutral on Aardvark Therapeutics, Lowers Price Target to $2
12 Health Care Stocks Moving In Friday's Intraday Session
Aardvark Therapeutics Says Current Prader-Willi Syndrome Drug Data Insufficient
Dow Tumbles Over 500 Points; American Express Shares Fall After Q3 Results
12 Health Care Stocks Moving In Friday's Pre-Market Session Aardvark Therapeutics Reports Exploratory Phase 3 HERO And OLE Data Showing Rapid Hunger Score Reductions With ARD-101 In PWS, FDA Lifts Clinical Hold And Company Targets New Phase 3 Trial
Your note
Sign in to keep a note on AARD — it syncs with the Stock Master app.
